Cargando...
Pharmacokinetic modeling of therapies for systemic lupus erythematosus
With the increasing use of different types of therapies in treating autoimmune diseases such as systemic lupus erythematosus (SLE), there is a need to utilize pharmacokinetic (PK) strategies to optimize the clinical outcome of these treatments. Various PK analysis approaches, including population PK...
Guardado en:
| Publicado en: | Expert Rev Clin Pharmacol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575755/ https://ncbi.nlm.nih.gov/pubmed/26143647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17512433.2015.1059751 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|